András Csejtei

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary.

István Kiss, Zsuzsa Orsós, Katalin Gombos et al. · PubMed · 2007 · 47 citations

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill et al. · European Journal of Cancer · 2017 · 46 citations

Breast Oncology, Medicine, Primary Analysis +7

GSTM, GSTT and p53 polymorphisms as modifiers of clinical outcome in colorectal cancer.

András Csejtei, Antal Tibold, Zsuzsa Varga et al. · PubMed · 2008 · 43 citations

Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population.

András Csejtei, Antal Tibold, Katalin Koltai et al. · PubMed · 2009 · 29 citations